First line management of prolonged convulsive seizures in children and adults: good practice points

Liesbeth De Waele1, Paul Boon, Berten Ceulemans

  • 1Department of Paediatric Neurology, University Hospitals Leuven, 49 Herestraat, 3000, Leuven, Belgium, liesbeth.dewaele@uzleuven.be.

Acta Neurologica Belgica
|September 11, 2013
PubMed

Insights

Rapidly stopping seizures is key to preventing status epilepticus. This paper outlines best practices for initial management of prolonged convulsive seizures before medical help arrives.

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Status epilepticus (SE) is a medical emergency requiring rapid intervention.
  • Prompt seizure termination is crucial for preventing long-term neurological damage.
  • Benzodiazepines are the established first-line emergency medication for seizures.

Framework:

  • This paper proposes "good practice points" for the pre-medical management of prolonged convulsive seizures.
  • Focuses on initial interventions in a non-medical setting.
  • Aims to standardize early-stage seizure management.

Implementation:

  • Provides guidance for the first-line treatment of prolonged convulsive seizures.
  • Covers both pediatric and adult populations.
  • Emphasizes actions to be taken before the arrival of trained medical personnel.

Implications:

  • Facilitates timely and effective emergency seizure management.
  • Potentially reduces morbidity and mortality associated with status epilepticus.
  • Empowers individuals to provide critical initial care during seizures.

Related Concept Videos

Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...